Mirtazapine Treatment of Anxiety in Children and Adolescents With Pervasive Developmental Disorders

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT01302964
Recruitment Status : Recruiting
First Posted : February 24, 2011
Last Update Posted : August 29, 2017
Autism Speaks
Information provided by (Responsible Party):
Christopher John McDougle, M.D., Massachusetts General Hospital

No Study Results Posted on for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : July 2018
  Estimated Study Completion Date : July 2018